3-Amino-5-(azepan-1-yl)-N-carbamimidoyl-6-(4-(trifluoromethyl)phenyl)pyrazine-2-carboxamide

ID: ALA4203024

Chembl Id: CHEMBL4203024

PubChem CID: 146029518

Max Phase: Preclinical

Molecular Formula: C19H22F3N7O

Molecular Weight: 421.43

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NC(=O)c1nc(-c2ccc(C(F)(F)F)cc2)c(N2CCCCCC2)nc1N

Standard InChI:  InChI=1S/C19H22F3N7O/c20-19(21,22)12-7-5-11(6-8-12)13-16(29-9-3-1-2-4-10-29)27-15(23)14(26-13)17(30)28-18(24)25/h5-8H,1-4,9-10H2,(H2,23,27)(H4,24,25,28,30)

Standard InChI Key:  DJXOPWDCWQNTGK-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4203024

    ---

Associated Targets(Human)

PLAU Tchem Urokinase-type plasminogen activator (2016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCNN1A Tclin Amiloride-sensitive sodium channel alpha-subunit (48 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCNN1B Tclin Amiloride-sensitive sodium channel subunit beta (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCNN1G Tclin Amiloride-sensitive sodium channel subunit gamma (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 421.43Molecular Weight (Monoisotopic): 421.1838AlogP: 2.75#Rotatable Bonds: 3
Polar Surface Area: 134.01Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.83CX Basic pKa: 6.59CX LogP: 3.82CX LogD: 3.76
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.44Np Likeness Score: -0.82

References

1. Buckley BJ, Aboelela A, Minaei E, Jiang LX, Xu Z, Ali U, Fildes K, Cheung CY, Cook SM, Johnson DC, Bachovchin DA, Cook GM, Apte M, Huang M, Ranson M, Kelso MJ..  (2018)  6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer.,  61  (18): [PMID:30130401] [10.1021/acs.jmedchem.8b00838]
2. Buckley BJ,Aboelela A,Majed H,Bujaroski RS,White KL,Powell AK,Wang W,Katneni K,Saunders J,Shackleford DM,Charman SA,Cook GM,Kelso MJ,Ranson M.  (2021)  Systematic evaluation of structure-property relationships and pharmacokinetics in 6-(hetero)aryl-substituted matched pair analogs of amiloride and 5-(N,N-hexamethylene)amiloride.,  37  [PMID:33799173] [10.1016/j.bmc.2021.116116]

Source